Metraipolis › archive › dc_0bc8f9015709

In Silico Design of Peptide Inhibitors Targeting HER2 for Lung Cancer Therapy — Europe PMC PMID:39682166

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/39682166
DOI
10.3390/cancers16233979
License (as archived)
solo-consultazione
Archived
2026-10-08T01:15:34.478Z
SHA-256 of the archived text
ef2ed3cb81ec977871c3cb55be6e4385a1bf40c9c33921f4868a59179249fd57
Stable URL of this page
https://metraipolis.com/documento/dc_0bc8f9015709

How to cite

In Silico Design of Peptide Inhibitors Targeting HER2 for Lung Cancer Therapy — Europe PMC PMID:39682166 — Europe PMC (en), https://europepmc.org/article/MED/39682166 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_0bc8f9015709 (Metraipolis archive dc_0bc8f9015709, sha256 ef2ed3cb81ec977871c3cb55be6e4385a1bf40c9c33921f4868a59179249fd57)
BibTeX
@misc{dc0bc8f9015709,
  title = {In Silico Design of Peptide Inhibitors Targeting HER2 for Lung Cancer Therapy — Europe PMC PMID:39682166},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/39682166},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_0bc8f9015709; sha256 ef2ed3cb81ec977871c3cb55be6e4385a1bf40c9c33921f4868a59179249fd57},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/39682166. Agents can read the archived copy with the MCP tool read_document.